⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MOLN News
Molecular Partners AG American Depositary Shares
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
globenewswire.com
MOLN
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
globenewswire.com
MOLN
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
globenewswire.com
MOLN
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
globenewswire.com
MOLN
Anti-Biofilm Agents Market to Worth Over USD 4.32 Billion By 2035 | Escalating Hospital Infection Rates Drive Urgent Clinical Agent Adoption and Market Growth says Astute Analytica
globenewswire.com
SNN
MOLN
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026
globenewswire.com
MOLN
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
MOLN
Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
MOLN
Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics
globenewswire.com
MOLN
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
globenewswire.com
MOLN